The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of TQB2102, a novel bispecific anti-HER2 antibody–drug conjugate, in patients with advanced solid tumors: Preliminary data from the first-in-human phase 1 trial.
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical
 
Shusen Wang
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer
 
Dan-yun Ruan
No Relationships to Disclose
 
Shaoyan Lin
No Relationships to Disclose
 
Fu-Rong Liu
No Relationships to Disclose
 
Hao-Xiang Wu
No Relationships to Disclose
 
Jia Huang
No Relationships to Disclose
 
Qiufan Zheng
No Relationships to Disclose
 
Kuikui Jiang
No Relationships to Disclose
 
Xiaobo Du
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Zhenyang Liu
No Relationships to Disclose
 
Junjie Peng
No Relationships to Disclose
 
Huihua Xiong
No Relationships to Disclose
 
Aili Suo
No Relationships to Disclose
 
Rongbo Lin
No Relationships to Disclose
 
Shuang Zhang
No Relationships to Disclose